Results show similar levels of virus undetectability in patients on ibalizumab-containing regimens as in controls, despite greater baseline severity of HIV Ibalizumab continues to demonstrate long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback